In Vivo Efficacy of Mefloquine for the Treatment of Falciparum Malaria in Brazil

Crispim Cerutti, Rui Rafael Durlacher, Filomena Euridice Carvalho de Alencar, Aluísio Augusto Cotrim Segurado, Lorrin Pang

The Journal of Infectious Diseases · 1999 · 34 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

Ninety-four patients with falciparum malaria were treated with mefloquine (1000-mg single dose) and remained hospitalized in a malaria-free area for a minimum of 28 days. There was 1 parasitologic failure (grade I resistance [RI]) for a 99% cure rate (95% confidence interval, 94.2%-99.7%). Mean parasite clearance time by thick smear was 45.7 h (SD, 11.4 h). The subject in whom therapy failed had a parasite clearance time (71 h) >2 SD above the population mean. His plasma mefloquine level 48 h after administration was lower (578 ng/mL) than the range of levels from 8 randomly selected cured subjects (834-2360 ng/mL). The IC50 to mefloquine for the recrudescent strain of the RI failure was in the upper 90th percentile of IC50 values from 30 cured subjects. These results show a high mefloquine cure rate but document the onset and mechanism of the emergence of resistance.

References

10